Prior research has shown that inhibiting FOSL1 expression via gene editing methods or small molecule inhibitors in cellular and animal models, markedly hinders the proliferation, migration and invasive potential of melanoma cells, while also diminishing tumor growth and metastasis (100). The gene discussed is FOSL1; the disease is neoplasm.